Antiinflammatory activities of CGRP modulating innate immune responses in health and disease

Current Protein and Peptide Science

Volumn 14, Issue 4, 2013, Pages 268-274

  Holzmann, Bernhard ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

CGRP; ICER; IL 10; Immunosuppression; Innate immunity; NF B; RAMP1; Sepsis

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR LIKE RECEPTOR; CD86 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; DOWN REGULATION; ENTERITIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEPSIS; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CALCITONIN GENE-RELATED PEPTIDE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; SEPSIS;

EID: 84888216536     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/13892037113149990046     Document Type: Article

References (76)

1. Steinman, L. Elaborate interactions between the immune and nervous systems. Nat. Immunol., 2004, 5, 575-581.
2. Metcalfe, D. D.; Baram, D.; Mekori, Y. A. Mast cells. Physiol. Rev., 1997, 77, 1033-1079.
3. Stead, R. H.; Tomioka, M.; Quinonez, G.; Simon, G. T.; Felten, S. Y.; Bienenstock, J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc. Natl. Acad. Sci. USA, 1987, 84, 2975-2979.
4. Weihe, E.; Müller, S.; Fink, T.; Zentel, H. J. Tachykinins, calcitonin gene-related peptide and neuropeptide Y in nerves of the mammalian thymus: interactions with mast cells in autonomic and sensory neuroimmunomodulation? Neurosci. Lett., 1989, 100, 77-82.
5. Weihe, E.; Nohr, D.; Michel, S.; Müller, S.; Zentel, H.-J.; Fink, T.; Krekel, J. Molecular anatomy of the neuro-immune connection. Int. J. Neurosci., 1991, 59, 1-23.
6. Hosoi, J.; Murphy, G. F.; Egan, C. L.; Lerner, E. A.; Grabbe, S.; Asahina, A.; Granstein, R. D. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature, 1993, 363, 159-163.
7. Naukkarinen, A.; Järvikallio, A.; Lakkakorpi, J.; Harvima, I. T.; Harvima, R. J.; Horsmanheimo, M. Quantitative histochemical analysis of mast cells and sensory nerves in psoriatic skin. J. Pathol., 1996, 180, 200-205.
8. Steinhoff, M.; Vergnolle, N.; Young, S. H.; Tognetto, M.; Amadesi, S.; Ennes, H. S.; Trevisani, M.; Hollenberg, M. D.; Wallage, J. L.; Caughey, G. H.; Mitchell, S. E.; Williams, L. M.; Geppetti, P.; Mayer, E. A.; Bunnett, N. W. Agonist of proteinaseactivated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med., 2000, 6, 151-158.
9. Andreeva, L.; Rang, H. P. Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vitro. Br. J. Pharmacol., 1993, 108, 185-190.
10. Jenkins, D. W.; Feniuk, W.; Humphrey, P. P. Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones. Br. J. Pharmacol., 2001, 134, 1296-1302.
11. Bracci-Laudiero, L.; Aloe, L.; Buanne, P.; Finn, A.; Stenfors, C.; Vigneti, E.; Theodorsson, E.; Lundeberg, T. NGF modulates CGRP synthesis in human B-lymphocytes: a possible anti-inflammatory action of NGF? J. Neuroimmunol., 2002, 123, 58-65.
12. Bracci-Laudiero, L.; Aloe, L.; Caroleo, M. C.; Buanne, P.; Costa, N.; Starace, G.; Lundeberg, T. Endogenous NGF regulates CGRP expression in human monocytes and affects HLA-DR and CD86 expression and IL-10 production. Blood, 2005, 106, 3507-3514.
13. Wang, H.; Xing, L.; Li, W.; Hou, L.; Guo, J.; Wang, X. Production and secretion of calcitonin gene-related peptide from human lymphocytes. J. Neuroimmunol., 2002, 130, 155-162.
14. Xing, L.; Guo, J.; Wang, X. Induction and expression of [-calcitonin gene-related peptide in rat T lymphocytes and its significance. J. Immunol., 2000, 165, 4359-4366.
15. Muff, R.; Born, W.; Lutz, T. A.; Fischer, J. A. Biological importance of the peptides of the calcitonin family as revealed by disruption and transfer of corresponding genes. Peptides, 2004, 25, 2027-2038.
16. Wimalawansa, S. J. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit. Rev. Neurobiol., 1997, 11, 167-239.
17. Mikami, N.; Watanabe, K.; Hashimoto, N.; Miyagi, Y.; Sueda, K.; Fukada, S.; Yamamoto, H.; Tsujikawa, K. Calcitonin gene-related peptide enhances experimental autoimmune encephalomyelitis by promoting Th17 cell functions. Int. Immunol., 2012, doi:10.1093/intimm/dxs075.
18. Tsujikawa, K.; Yayama, K.; Hayashi, T.; Matsushita, H.; Yamaguchi, T.; Shigeno, T.; Ogitani, Y.; Hirayama, M.; Kato, T.; Fukada, S.; Takatori, S.; Kawasaki, H.; Okamoto, H.; Ikawa, M.; Okabe, M.; Yamamoto, H. Hypertension and dysreglated proinflammatory cytokine production in receptor activitymodifying protein 1-deficient mice. Proc. Natl. Acad. Sci. USA, 2007, 104, 16702-16707.
19. Brain, S. D.; Grant, A. D. Vascular actions of calcitonin generelated peptide and adrenomedullin. Physiol. Rev., 2004, 84, 903-934.
20. Holzmann, B. Modulation of immune responses by the neuropeptide CGRP. Amino Acids, 2011, doi:10.1007/s00726-011-1161-2.
21. Benemei, S.; Nicoletti, P.; Capone, J. G.; Geppetti, P. CGRP receptors in the control of pain and inflammation. Curr. Opin. Pharmacol., 2009, 9, 9-14.
22. Hay, D. L.; Poyner, D. R.; Sexton, P. M. GPCR modulation by RAMPs. Pharmacol. Ther., 2006, 109, 173-197.
23. Walker, C. S.; Conner, A. C.; Poyner, D. R.; Hay, D. L. Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends Pharmacol. Sci., 2010, 31, 476-483.
24. Hay, D. L.; Poyner, D. R.; Quirion, R. International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor. Pharmacol. Rev., 2008, 60, 143-145.
25. Parameswaran, N.; Spielman, W. S. RAMPs: the past, present and future. Trends Biochem. Sci., 2006, 31, 631-638.
26. Hilairet, S.; Foord, S. M.; Marshall, F. H.; Bouvier, M. Proteinprotein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins. J. Biol. Chem., 2001, 276, 29575-29581.
27. ter Haar, E.; Koth, C. M.; Abdul-Manan, N.; Swenson, L.; Coll, J. T.; Lippke, J. A.; Lepre, C. A.; Garcia-Guzman, M.; Moore, J. M. Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure, 2010, 18, 1083-1093.
28. Carucci, J. A.; Ignatius, R.; Wei, Y.; Cypess, A. M.; Schaer, D. A.; Pope, M.; Steinman, R. M.; Mojsov, S. Calcitonin gene-related peptide decreases expression of HLA-DR and CD86 by human dendritic cells and dampens dendritic cell-driven T cellproliferative responses via the type I calcitonin gene-related peptide receptor. J. Immunol., 2000, 164, 3494-3499.
29. Ding, W.; Stohl, L. L.; Wagner, J. A.; Granstein, R. D. Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. J. Immunol., 2008, 181, 6020-6026.
30. Fernandez, S.; Knopf, M. A.; Bjork, S. K.; McGillis, J. P. Bone marrow-derived macrophages express functional CGRP receptors and respond to CGRP by increasing transcription of c-fos and IL-6 mRNA. Cell. Immunol., 2001, 209, 140-148.
31. Harzenetter, M.; Novotny, A. R.; Gais, P.; Molina, C. A.; Altmayr, F.; Holzmann, B. Negative regulation of TLR responses by the neuropeptide CGRP is mediated by the transcriptional repressor ICER. J. Immunol., 2007, 179, 607-615.
32. Harzenetter, M.; Keller, U.; Beer, S.; Riedl, C.; Peschel, C.; Holzmann, B. Regulation and function of the CGRP receptor complex in human granulopoiesis. Exp. Hematol., 2002, 30, 306-312.
33. Fox, F. E.; Kubin, M.; Cassin, M.; Niu, Z.; Hosoi, J.; Torii, H.; Granstein, R. D.; Trinchieri, G.; Rook, A. H. Calcitonin generelated peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12. J. Invest. Dermatol., 1997, 108, 43-48.
34. Torii, H.; Hosoi, J.; Beissert, S.; Xu, S.; Fox, F. E.; Asahina, A.; Takashima, A.; Rook, A. H.; Granstein, R. D. Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide. J. Leukoc. Biol., 1997, 61, 216-223.
35. Altmayr, F.; Jusek, G.; Holzmann, B. The neuropeptide calcitonin gene-related peptide causes repression of tumor necrosis factor transcription and suppression of ATF-2 promoter recruitment in Toll-like receptor-stimulated dendritic cells. J. Biol. Chem., 2010, 285, 3525-3531.
36. Gomes, R. N.; Castro-Faria-Neto, H. C.; Bozza, P. T.; Soares, M. B. P.; Shoemaker, C. B.; David, J. R.; Bozza, M. T. Calcitonin gene-related peptide inhibits local acute inflammation and protects mice against lethal endotoxemia. Shock, 2005, 24, 590-594.
37. Jusek, G.; Reim, D.; Tsujikawa, K.; Holzmann, B. Deficiency of the CGRP receptor component RAMP1 attenuates immunsuppression during the early phase of septic peritonitis. Immunobiology, 2012, 217, 761-767.
38. Umeda, Y.; Arisawa, M. Inhibition of natural killer cell activity by calcitonin gene-related peptide. Immunopharmacol. Immunotoxicol., 1989, 11, 309-320.
39. Asahina, A.; Moro, O.; Hosoi, J.; Lerner, E. A.; Xu, S.; Takashima, A.; Granstein, R. D. Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects. Proc. Natl. Acad. Sci. USA, 1995, 92, 8323-8327.
40. Asahina, A.; Hosoi, J.; Beissert, S.; Stratigos, A.; Granstein, R. D. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J. Immunol., 1995, 154, 3056-3061.
41. Kitazawa, T.; Streilein, J. W. Hapten-specific tolerance promoted by calcitonin gene-related peptide. J. Invest. Dermatol., 2000, 115, 942-948.
42. Buckley, T. L.; Brain, S. D.; Collins, P. D.; Williams, T. J. Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide. J. Immunol., 1991, 146, 3424-3430.
43. Huang, J.; Stohl, L. L.; Zhou, X.; Ding, W.; Granstein, R. D. Calcitonin gene-related peptide inhibits chemokine production by human dermal microvascular endothelial cells. Brain Behav. Immun., 2011, 25, 787-799.
44. Sung, C. P.; Arleth, A. J.; Aiyar, N.; Bhatnagar, P. K.; Lysko, P. G.; Feuerstein, G. CGRP stimulates the adhesion of leukocytes to vascular endothelial cells. Peptides, 1992, 13, 429-434.
45. Evans, B. N.; Rosenblatt, M. I.; Mnayer, L. O.; Oliver, K. R.; Dickerson, I. M. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J. Biol. Chem., 2000, 275, 31438-31443.
46. Prado, M. A.; Evans-Bain, B.; Dickerson, I. M. Receptor component protein (RCP): a member of a multi-protein complex required for G-protein-coupled signal transduction. Biochem. Soc. Trans., 2002, 30, 460-464.
47. 2+ signaling pathways. Mol. Cell Biochem., 1999, 197, 179-185.
48. Drissi, H.; Lasmoles, F.; Le Mellay, V.; Marie, P. J.; Lieberherr, M. Activation of phospholipase C-AA1 via G11q/11 during calcium mobilization by calcitonin gene-related peptide. J. Biol. Chem., 1998, 273, 20168-20174.
49. Morara, S.; Wang, L.-P.; Filippov, V.; Dickerson, I. M.; Grohovaz, F.; Provini, L.; Kettenmann, H. Calcitonin gene-related peptide (CGRP) triggers Ca2+ responses in cultured astrocytes and in Bergmann glial cells from cerebellar slices. Eur. J. Neurosci., 2011, 28, 2213-2220.
50. Hilairet, S.; Bélanger, C.; Bertrand, J.; Laperriére, A.; Foord, S. M.; Bouvier, M. Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activitymodifying protein 1 (RAMP1), and pp-arrestin. J. Biol. Chem., 2001, 276, 42182-42190.
51. Bomberger, J. M.; Parameswaran, N.; Hall, C. S.; Aiyar, N.; Spielman, W. S. Novel function for receptor activity-modifying proteins (RAMPs) in post-endocyctic receptor trafficking. J. Biol. Chem., 2005, 280, 9297-9307.
52. Cottrell, G. S.; Padilla, B.; Pikios, S.; Roosterman, D.; Steinhoff, M.; Grady, E. F.; Bunnett, N. W. Post-endocytic sorting of calcitonin receptor-like receptor and receptor activity modifying protein 1. J. Biol. Chem., 2007, 282, 12260-12271.
53. Tokoyoda, K.; Tsujikawa, K.; Matsushita, H.; Ono, Y.; Hayashi, T.; Harada, Y.; Abe, R.; Kubo, M.; Yamamoto, H. Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells. Int. Immunol., 2004, 16, 643-653.
54. Mayr, B.; Montminy, M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol., 2001, 2, 599-609.
55. Ouyang, W.; Rutz, S.; Crellin, N. K.; Valdez, P. A.; Hymowitz, S. G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol., 2011, 29, 71-109.
56. Wen, A. Y.; Sakamoto, K. M.; Miller, L. S. The role of the transcription factor CREB in immune function. J. Immunol., 2010, 185, 6413-6419.
57. Saraiva, M.; O'Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol., 2010, 10, 170-181.
58. Mao, D.; Warner, E. A.; Gurwitch, S. A.; Dowd, D. R. Differential regulation and transcriptional control of immediate early gene expression in forskolin-treated WEHI7.2 thymoma cells. Mol. Endocrinol., 2010, 12, 492-503.
59. Minguet, S.; Huber, M.; Rosenkranz, L.; Schamel, W. W. A.; Reth, M.; Brummer, T. Adenosine and cAMP are potent inhibitors of the NF-NNB pathway downstream of immunoreceptors. Eur. J. Immunol., 2005, 35, 31-41.
60. Neumann, M.; Grieshammer, T.; Chuvpilo, S.; Kneitz, B.; Lohoff, M.; Schimpl, A.; Franza, B. R.; Serfling, E. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J., 2004, 14, 1991-2004.
61. Guan, H.; Hou, S.; Ricciardi, R. P. DNA binding of repressor nuclear factor-nnB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit. J. Biol. Chem., 2005, 280, 9957-9962.
62. Bodor, J.; Habener, J. F. Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes. Proc. Natl. Acad. Sci. USA, 1998, 273, 9544-9551.
63. Bodor, J.; Spetz, A.-L.; Strominger, J. L.; Habener, J. F. cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes. Proc. Natl. Acad. Sci. USA, 1996, 93, 3536-3541.
64. Ding, W.; Wagner, J. A.; Granstein, R. D. CGRP, PACAP, and VIP modulate langernhans cell function by inhibiting NF-VVB activation. J. Invest. Dermatol., 2007, 127, 2357-2367.
65. Wirtz, S.; Neufert, C.; Weigmann, B.; Neurath, M. F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc., 2007, 2, 541-546.
66. Reinshagen, M.; Flämig, G.; Ernst, S.; Geerling, I.; Wong, H.; Walsh, J. H.; Eysselein, V. E.; Adler, G. Calcitonin gene-related peptide mediates the protective effects of sensory nerves in a model of colonic injury. J. Pharmacol. Exp. Ther., 1998, 286, 657-661.
67. Engel, M. A.; Khalil, M.; Siklosi, N.; Mueller-Tribbensee, S. M.; Neuhuber, L. N.; Neurath, M. F.; Becker, C.; Reeh, P. W. Opposite effects of substance P and calcitonin gene-related peptide in oxazolone colitis. Dig. Liver Dis., 2012, 44, 24-29.
68. Engel, M. A.; Leffer, A.; Niedermirtl, F.; Babes, A.; Zimmermann, K.; Filipovic, M. R.; Izydorczyk, I.; Eberhardt, M.; Kichko, T. I.; Mueller-Tribbensee, S. M.; Khalil, M.; Siklosi, N.; Nau, C.; Ivanovic-Burmazovic, I.; Neuhuber, W. L.; Becker, C.; Neurath, M.; Reeh, P. W. TRPA1 and substance P mediate colitis in mice. Gastroenterology, 2011, 141, 1346-1358.
69. Hue, S.; Ahern, P.; Buonocore, S.; Kullberg, M. C.; Cua, D. J.; McKenzie, B. S.; Powrie, F.; Maloy, K. J. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med., 2006, 203, 2473-2483.
70. Yen, D.; Cheung, J.; Scheerens, H.; Poulet, F.; McClanahan, T.; McKenzie, B.; Kleinschek, M. A.; Owyang, A.; Mattson, J.; Blumenschein, W.; Murphy, E.; Sathe, M.; Cua, D. J.; Kastelein, R. A.; Rennick, D. IL-23 is essential for T cell-mediated colitits and promotes inflammation via IL-17 and IL-6. J. Clin. Invest., 2003, 116, 1310-1316.
71. Cua, D. J.; Sherlock, J.; Chen, Y.; Murphy, C. A.; Joyce, B.; Seymour, B.; Lucian, L. A.; To, W.; Kwan, S.; Churakova, T.; Zurawski, S.; Wiekowski, M.; Lira, S. A.; Gorman, D.; Kastelein, R. A.; Sedgwick, J. D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature, 2003, 421, 744-748.
72. Beer, S.; Weighardt, H.; Emmanuilidis, K.; Harzenetter, M.; Matevossian, E.; Heidecke, C. D.; Bartels, H.; Siewert, J. R.; Holzmann, B. Systemic neuropeptide levels as predictive indicators for lethal outcome in patients with postoperative sepsis. Crit. Care Med., 2002, 30, 1794-1798.
73. Arnalich, F.; Sanchez, J. F.; Martinez, M.; Jiménez, M.; Lopez, J.; Vazquez, J. J.; Hernanz, A. Changes in plasma concentrations of vasoactive neuropeptides in patients with sepsis and septic shock. Life Sci., 1995, 56, 75-81.
74. De Winter, B. Y.; Bredenoord, A. J.; Van Nassauw, L. V.; De Man, J. G.; De Schepper, H. U.; Timmermans, J. P.; Pelckmans, P. A. Involvement of afferent neurons in the pathogenesis of endotoxininduced ileus in mice: role of CGRP and TRPV1 receptors. Eur. J. Pharmacol., 2009, 615, 177-184.
75. Weihe, E.; Bette, M.; Preuss, M. A.; Faber, M.; Schafer, M. K.; Rehnelt, J.; Schnell, M. J.; Dietzschold, B. Role of virus-induced neuropeptides in the brain in the pathogenesis of rabies. Dev. Biol. (Basel), 2008, 131, 73-81.
76. Kroeger, I.; Erhardt, A.; Abt, D.; Fischer, M.; Biburger, M.; Rau, T.; Neuhuber, W. L.; Tiegs, G. The neuropeptide calcitonin generelated peptide (CGRP) prevents inflammatory liver injury in mice. J. Hepatol., 2009, 51, 342-353.